Animation showing prescription bottle with arrow going up, indicating increase
Jun 08, 2021

Analysis suggests Medicare Part B reimbursement encourages high drug prices

Launch prices for new drugs have doubled since 2005, according to research from Duke University’s Fuqua School of Business. The data links the high prices to a 2005 change in the way Medicare reimburses doctors and other providers for Part B medications, which are drugs and treatments delivered in outpatient settings, said David... read more